Estimates of prostate cancer risk associated with being a MSR1*999C>T mutation carrier
| . | Logistic regression, OR (95% CI) . | Modified segregation analysis . | . | |
|---|---|---|---|---|
| . | . | RR (95% CI) . | Allele frequency (95% CI) . | |
| United Kingdom | 1.16 (0.52, 2.57) | 1.05 (0.43, 2.57) | 0.010 (0.002, 0.019) | |
| Australia | 1.37 (0.93, 2.02) | 1.48 (0.43, 2.57) | 0.010 (0.007, 0.014) | |
| Other | 1.07 (0.29, 4.02) | 0.72 (0.28, 1.82) | 0.016 (0.000, 0.031) | |
| All | 1.31 (0.93, 1.84) | 1.20 (0.87, 1.66) | 0.011 (0.008, 0.014) | |
| . | Logistic regression, OR (95% CI) . | Modified segregation analysis . | . | |
|---|---|---|---|---|
| . | . | RR (95% CI) . | Allele frequency (95% CI) . | |
| United Kingdom | 1.16 (0.52, 2.57) | 1.05 (0.43, 2.57) | 0.010 (0.002, 0.019) | |
| Australia | 1.37 (0.93, 2.02) | 1.48 (0.43, 2.57) | 0.010 (0.007, 0.014) | |
| Other | 1.07 (0.29, 4.02) | 0.72 (0.28, 1.82) | 0.016 (0.000, 0.031) | |
| All | 1.31 (0.93, 1.84) | 1.20 (0.87, 1.66) | 0.011 (0.008, 0.014) | |
Abbreviations: OR, odds ratio; RR, relative risk.